Drug Profile
Granulocyte colony stimulating factor - Kancer
Alternative Names: OGCSF - Kancer; Oral Granulocyte Colony Stimulating Factor - KancerLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Kancer
- Class
- Mechanism of Action Granulocyte colony-stimulating factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Neutropenia
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Neutropenia(Chemotherapy-induced) in United Kingdom (PO)
- 06 Jul 2016 Early research in Neutropenia (Chemotherapy-induced) in United Kingdom (PO)